Medical Properties Trust, Inc. (NYSE:MPW)‘s stock had its “buy” rating reaffirmed by research analysts at Royal Bank Of Canada in a report issued on Monday. They currently have a $16.00 price objective on the real estate investment trust’s stock. Royal Bank Of Canada’s target price suggests a potential upside of 24.22% from the company’s previous close.

A number of other equities analysts also recently weighed in on the stock. Jefferies Group LLC raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating and raised their target price for the company from $13.00 to $15.00 in a research note on Friday, April 7th. Deutsche Bank AG raised their target price on shares of Medical Properties Trust from $13.50 to $15.00 and gave the company a “buy” rating in a research note on Thursday, April 6th. ValuEngine downgraded shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. BidaskClub raised shares of Medical Properties Trust from a “sell” rating to a “hold” rating in a research note on Saturday, June 10th. Finally, Zacks Investment Research raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating and set a $15.00 target price for the company in a research note on Wednesday, July 19th. Two analysts have rated the stock with a sell rating, six have issued a hold rating and seven have assigned a buy rating to the company. Medical Properties Trust has a consensus rating of “Hold” and a consensus price target of $14.20.

Shares of Medical Properties Trust (NYSE:MPW) traded down 1.68% during midday trading on Monday, hitting $12.88. The company’s stock had a trading volume of 2,354,500 shares. The firm has a market cap of $4.14 billion, a P/E ratio of 15.46 and a beta of 0.89. Medical Properties Trust has a 52-week low of $11.54 and a 52-week high of $15.91. The stock’s 50 day moving average is $13.03 and its 200-day moving average is $13.02.

Medical Properties Trust (NYSE:MPW) last announced its earnings results on Thursday, May 4th. The real estate investment trust reported $0.33 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.33. Medical Properties Trust had a net margin of 41.79% and a return on equity of 7.94%. The business had revenue of $156.40 million during the quarter, compared to the consensus estimate of $156.91 million. During the same quarter last year, the firm earned $0.35 earnings per share. The business’s revenue for the quarter was up 15.9% on a year-over-year basis. Equities analysts predict that Medical Properties Trust will post $0.87 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: This article was first posted by American Banking News and is the sole property of of American Banking News. If you are reading this article on another publication, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://www.americanbankingnews.com/2017/07/24/medical-properties-trust-inc-mpw-stock-rating-reaffirmed-by-royal-bank-of-canada.html.

In related news, CFO R Steven Hamner sold 85,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 14th. The shares were sold at an average price of $13.36, for a total transaction of $1,135,600.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.00% of the stock is owned by company insiders.

Several large investors have recently made changes to their positions in the stock. IFP Advisors Inc increased its stake in shares of Medical Properties Trust by 15.1% in the first quarter. IFP Advisors Inc now owns 9,009 shares of the real estate investment trust’s stock valued at $116,000 after buying an additional 1,182 shares during the period. Neuburgh Advisers LLC increased its stake in shares of Medical Properties Trust by 6.2% in the first quarter. Neuburgh Advisers LLC now owns 10,582 shares of the real estate investment trust’s stock valued at $136,000 after buying an additional 616 shares during the period. Greenwich Wealth Management LLC purchased a new stake in shares of Medical Properties Trust during the first quarter valued at $141,000. Huntington National Bank increased its stake in shares of Medical Properties Trust by 70.1% in the first quarter. Huntington National Bank now owns 11,434 shares of the real estate investment trust’s stock valued at $147,000 after buying an additional 4,712 shares during the period. Finally, GW&K Investment Management LLC purchased a new stake in shares of Medical Properties Trust during the first quarter valued at $148,000. 78.48% of the stock is owned by institutional investors.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.